Publication:
Management of central nervous system infections, Vientiane, Laos, 2003–2011

dc.contributor.authorAudrey Dubot-Pérèsen_US
dc.contributor.authorMayfong Mayxayen_US
dc.contributor.authorRattanaphone Phetsouvanhen_US
dc.contributor.authorSue J. Leeen_US
dc.contributor.authorSayaphet Rattanavongen_US
dc.contributor.authorManivanh Vongsouvathen_US
dc.contributor.authorViengmon Davongen_US
dc.contributor.authorVilada Chansamouthen_US
dc.contributor.authorKoukeo Phommasoneen_US
dc.contributor.authorCatrin Mooreen_US
dc.contributor.authorSabine Dittrichen_US
dc.contributor.authorOlay Lattanaen_US
dc.contributor.authorJoy Sirisouken_US
dc.contributor.authorPhonelavanh Phouminen_US
dc.contributor.authorPhonepasith Panyanivongen_US
dc.contributor.authorAmphonesavanh Sengduangphachanhen_US
dc.contributor.authorBountoy Sibounheuangen_US
dc.contributor.authorAnisone Chanthongthipen_US
dc.contributor.authorManivone Simmalavongen_US
dc.contributor.authorDavanh Sengdatkaen_US
dc.contributor.authorAmphaivanh Seubsanithen_US
dc.contributor.authorValy Keoluangkoten_US
dc.contributor.authorPrasith Phimmasoneen_US
dc.contributor.authorKongkham Sisouten_US
dc.contributor.authorKhamsai Detleuxayen_US
dc.contributor.authorKhonesavanh Luangxayen_US
dc.contributor.authorInpanh Phouangsouvanhen_US
dc.contributor.authorScott B. Craigen_US
dc.contributor.authorSuhella M. Tulsianien_US
dc.contributor.authorMary Anne Burnsen_US
dc.contributor.authorDavid A.B. Danceen_US
dc.contributor.authorStuart D. Blacksellen_US
dc.contributor.authorXavier de Lamballerieen_US
dc.contributor.authorPaul N. Newtonen_US
dc.contributor.otherAix Marseille Universitéen_US
dc.contributor.otherLondon School of Hygiene & Tropical Medicineen_US
dc.contributor.otherUniversity of Oxforden_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherQueensland Healthen_US
dc.contributor.otherInstitute of Research and Education Developmenten_US
dc.contributor.otherMahosot Hospitalen_US
dc.date.accessioned2020-01-27T09:53:52Z
dc.date.available2020-01-27T09:53:52Z
dc.date.issued2019-05-01en_US
dc.description.abstract© 2019, Centers for Disease Control and Prevention (CDC). All Rights Reserved. During 2003–2011, we recruited 1,065 patients of all ages admitted to Mahosot Hospital (Vientiane, Laos) with suspected central nervous system (CNS) infection. Etiologies were laboratory confirmed for 42.3% of patients, who mostly had infections with emerging pathogens: viruses in 16.2% (mainly Japanese encephalitis virus [8.8%]); bacteria in 16.4% (including Orientia tsutsugamushi [2.9%], Leptospira spp. [2.3%], and Rickettsia spp. [2.3%]); and Cryptococcus spp. fungi in 6.6%. We observed no significant differences in distribution of clinical encephalitis and meningitis by bacterial or viral etiology. However, patients with bacterial CNS infection were more likely to have a history of diabetes than others. Death (26.3%) was associated with low Glasgow Coma Scale score, and the mortality rate was higher for patients with bacterial than viral infections. No clinical or laboratory variables could guide antibiotic selection. We conclude that high-dependency units and first-line treatment with ceftriaxone and doxycycline for suspected CNS infections could improve patient survival in Laos.en_US
dc.identifier.citationEmerging Infectious Diseases. Vol.25, No.5 (2019), 898-910en_US
dc.identifier.doi10.3201/eid2505.180914en_US
dc.identifier.issn10806059en_US
dc.identifier.issn10806040en_US
dc.identifier.other2-s2.0-85065015582en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/51704
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065015582&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleManagement of central nervous system infections, Vientiane, Laos, 2003–2011en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065015582&origin=inwarden_US

Files

Collections